Valuation
LKFTLakefront Biotherapeutics
StockNasdaqBelgiumHealth careEU retail: available
+0.8% today · +2.4% over a year
No score: too little data.
Quality: among the best of its peers. No dividend.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | LKFT | Sector median | vs median |
|---|---|---|---|
| P/E | — | 22.4 · n=28 | — |
| P/B | — | 3.6 · n=45 | — |
| P/S | — | 4.5 · n=40 | — |
| EV/EBIT | — | 20.8 · n=28 | — |
| Free-cash-flow yield | — | 3.5% · n=41 | — |
| Dividend yield | 0.00% | 0.12% · n=100 | 100% below |
| Return on equity | 10.5% | 6.8% · n=56 | 55% above |
| Return on invested capital | 9.9% | 7.0% · n=47 | 40% above |
| Gross margin | 97.3% | 70.2% · n=39 | 39% above |
| Net debt / EBITDA | — | 1.39 · n=26 | — |
Sector peers
The largest companies of the same sector and region.
| NVSNovartis AG | 21.3 | 6.5 | 17.9 | 5.9% | 2.5% | 9/10 |
|---|---|---|---|---|---|---|
| NOVNNovartis AG | 21.2 | 6.4 | 17.8 | 5.9% | 2.9% | 10/10 |
| AZNAstraZeneca plc | 25.7 | 5.4 | 20.9 | 4.5% | 1.9% | 6/10 |
| AZNAstraZeneca PLC | 25.7 | 5.4 | 20.9 | 4.5% | 1.3% | 6/10 |
| NVONovo Nordisk A/S | 11.2 | 5.9 | 9.8 | 5.2% | 4.8% | 7/10 |
| GSKGSK plc | 13.8 | 4.8 | 11.3 | 8.1% | 3.7% | 10/10 |
| SNYSanofi | 11.8 | 1.3 | 16.3 | 7.8% | 5.0% | 7/10 |
| SANSanofi SA | 11.8 | 1.3 | 16.2 | 7.8% | 5.5% | 8/10 |
| TEVATeva Pharmaceutical Industries Limited | 66.0 | 6.0 | 37.2 | 2.9% | 0.0% | 6/10 |
| ALCAlcon | 34.7 | 1.5 | 27.3 | 5.1% | 0.4% | 4/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 26 Mar 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.